About HoneyNaps
HoneyNaps is a company based in Seoul (South Korea) founded in 2015. HoneyNaps has raised $15.5 million across 3 funding rounds from investors including Industrial Bank of Korea, Hi Investment and QUAD Investment Management. HoneyNaps offers products and services including SOMNUM Platform, AI Disease Diagnosis Software, Real-time Sleep Monitoring System, and Bio-signal Management Platform. HoneyNaps operates in a competitive market with competitors including Muse, Oura, Jawbone, Biotricity and Sunrise, among others.
- Headquarter Seoul, South Korea
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
- Legal Name Honeynaps Co., Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$15.5 M (USD)
in 3 rounds
-
Latest Funding Round
$11.6 M (USD), Series B
May 07, 2024
-
Investors
Industrial Bank of Korea
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HoneyNaps
HoneyNaps offers a comprehensive portfolio of products and services, including SOMNUM Platform, AI Disease Diagnosis Software, Real-time Sleep Monitoring System, and Bio-signal Management Platform.
Platform for sharing sleep data with medical professionals worldwide.
Software using AI to analyze bio-signals for disease detection.
System for real-time tracking and analysis of sleep bio-signals.
Platform for managing and analyzing health-related bio-signals.
Funding Insights of HoneyNaps
HoneyNaps has successfully raised a total of $15.5M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $11.6 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in HoneyNaps
HoneyNaps has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Industrial Bank of Korea, Hi Investment and QUAD Investment Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Industrial bank
|
Locked | Locked | Locked | |
|
Investment management services are provided by QUAD Investment Management.
|
Locked | Locked | Locked |
Investor details for HoneyNaps
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by HoneyNaps
Investment portfolio details for HoneyNaps
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - HoneyNaps
Detailed financials for HoneyNaps
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Honeynaps Comparisons
Peer comparison for HoneyNaps
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of HoneyNaps
HoneyNaps operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Muse, Oura, Jawbone, Biotricity and Sunrise, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
EEG-powered headbands for meditation and sleep biofeedback are developed.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
|
| Locked | Locked | Locked |
Provider of wearable devices for activity and sleep tracking
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
Sunrise is focused on sleep apnea diagnostic solutions.
|
|
| Locked | Locked | Locked |
Sleep quality is monitored via bedside devices and mobile apps.
|
Detailed competitors of HoneyNaps
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Honeynaps
Complete news archive for HoneyNaps
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HoneyNaps
HoneyNaps was founded in 2015 and raised its 1st funding round 4 years after it was founded.
HoneyNaps is headquartered in Seoul, South Korea.
HoneyNaps is a funded company, having raised a total of $15.5M across 3 funding rounds to date.
HoneyNaps was founded in 2015 in Seoul, South Korea, within the health technology sector. AI-driven systems for diagnosing sleep disorders and monitoring bio-signals are created by the company. Real-time bio-signal monitoring platforms, analysis tools, and disease diagnosis software are provided. Therapeutic options for sleep disorders are also offered. Operations emphasize improved disease prediction and enhanced access to medical treatments through bio-signal technology.
HoneyNaps offers SOMNUM Platform, AI Disease Diagnosis Software, Real-time Sleep Monitoring System, and Bio-signal Management Platform.
HoneyNaps has 3 investors. Key investors include Industrial Bank of Korea, Hi Investment, and QUAD Investment Management.